Susquehanna downgrades Vertex Pharmaceuticals (NASDAQ: VRTX) from Positive to Neutral.

The firm highlighted that Schering-Plough's (NYSE: SGP) boceprevir ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE